Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Erratum

  • You have access
    Correction to “Protective Effect of Anwulignan on Gastric Injury Induced by Indomethacin in Mice”
    Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 204; DOI: https://doi.org/10.1124/jpet.121.001055err
  • You have access
    Correction to “Interactive Effects of µ-Opioid and Adrenergic-α2 Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine”
    Journal of Pharmacology and Experimental Therapeutics February 2023, 384 (2) 326; DOI: https://doi.org/10.1124/jpet.122.001192err
  • You have access
    Correction to “Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ-Opioid Receptor and Opioid-Like Behavioral Effects in Rats”
    Journal of Pharmacology and Experimental Therapeutics December 2022, 383 (3) 250; DOI: https://doi.org/10.1124/jpet.120.000189err
  • You have access
    Correction to “Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases”
    Journal of Pharmacology and Experimental Therapeutics December 2022, 383 (3) 251; DOI: https://doi.org/10.1124/jpet.121.001069err
  • You have access
    Correction to “The Skeletal Muscle Relaxer Cyclobenzaprine Is a Potent Non-Competitive Antagonist of Histamine H1 Receptors”
    Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 274; DOI: https://doi.org/10.1124/jpet.121.000998err
  • You have access
    Correction to “Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity”
    Journal of Pharmacology and Experimental Therapeutics April 2022, 381 (1) 67; DOI: https://doi.org/10.1124/jpet.121.000821err
  • You have access
    Correction to “A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor ɣ with Excellent Effect on Insulin Resistance and Type 2 Diabetes”
    Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 90-91; DOI: https://doi.org/10.1124/jpet.115.223107err
  • You have access
    Correction to “Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II – Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertensin”
    Journal of Pharmacology and Experimental Therapeutics September 2021, 378 (3) 322; DOI: https://doi.org/10.1124/jpet.121.000525err
  • You have access
    Correction to “Inhibition of Glucose-6-Phosphate Dehydrogenase Activity Attenuates Right Ventricle Pressure and Hypertrophy Elicited by VEGFR Inhibitor + Hypoxia”
    Journal of Pharmacology and Experimental Therapeutics August 2021, 378 (2) 69; DOI: https://doi.org/10.1124/jpet.120.000166err
  • You have access
    Correction to “Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome”
    Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 368; DOI: https://doi.org/10.1124/jpet.119.262238err

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 19
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics